Synthetic Lethality and Cancer Therapy: Lessons Learned from the Development of PARP Inhibitors
Year: 2014
Type: review
Source: Annual Review of Medicine
Institutions: Institute of Cancer Research, King's College London
Language: English
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: closed
Funders: Wellcome Trust, Cancer Research UK
Award: G2368474871
OpenAlex ID: W2123588904
